Fig1: Western blot analysis of Cytokeratin 19 on MCF-7 cell lysates using anti- Cytokeratin 19 antibody at 1/10,000 dilution.
Fig2: ICC staining Cytokeratin 19 in Ags cells (green). The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.
Fig3: Immunohistochemical analysis of paraffin-embedded human liver tissue using anti-Cytokeratin 19 antibody. Counter stained with hematoxylin.
Fig4: Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using anti-Cytokeratin 19 antibody. Counter stained with hematoxylin.
Fig5: Immunohistochemical analysis of paraffin-embedded human stomach carcinoma tissue using anti-Cytokeratin 19 antibody. Counter stained with hematoxylin.
Fig6: Immunohistochemical analysis of paraffin-embedded mouse liver tissue using anti-Cytokeratin 19 antibody. Counter stained with hematoxylin.
Fig7: Flow cytometric analysis of MCF-7 cells with Cytokeratin 19 antibody at 1/50 dilution (blue) compared with an unlabelled control (cells without incubation with primary antibody; red). Alexa Fluor 488-conjugated goat anti-rabbit IgG was used as the secondary antibody.
Product Name | Cytokeratin 19 [SA30-06] |
---|---|
Antibody Type | Primary Antibodies |
Product description |
|
Immunogen | recombinant protein |
Clonality | Monoclonal |
---|---|
Isotype | IgG |
Host Species | Recombinant rabbit |
Tested Applications | |
WB:1:5,000-1:10,000 ICC:1:50-1:200 IHC:1:50-1:200 FC:1:10-1:100 |
|
Species Reactivity | |
Concentration | 1 mg/mL. |
Alternative Names | 40 kDa keratin intermediate filament antibody
CK 19 antibody
CK-19 antibody
CK19 antibody
Cytokeratin 19 antibody
Cytokeratin-19 antibody
K19 antibody
K1C19_HUMAN antibody
K1CS antibody
Keratin 19 antibody
Keratin type I 40 kD antibody
Keratin type I 40kD antibody
Keratin type I cytoskeletal 19 antibody
Keratin type I cytoskeletal 19 antibody Keratin type I 40 kd antibody Keratin-19 antibody KRT19 antibody MGC15366 antibody |
---|---|
Molecular Weight(MW) | 40 kDa |
Cellular Localization | Cytoplasm |
SwissProt ID | P08727 P19001 |
---|
Fig1: Western blot analysis of Cytokeratin 19 on MCF-7 cell lysates using anti- Cytokeratin 19 antibody at 1/10,000 dilution.
Fig2: ICC staining Cytokeratin 19 in Ags cells (green). The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.
Fig3: Immunohistochemical analysis of paraffin-embedded human liver tissue using anti-Cytokeratin 19 antibody. Counter stained with hematoxylin.
Fig4: Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using anti-Cytokeratin 19 antibody. Counter stained with hematoxylin.
Fig5: Immunohistochemical analysis of paraffin-embedded human stomach carcinoma tissue using anti-Cytokeratin 19 antibody. Counter stained with hematoxylin.
Fig6: Immunohistochemical analysis of paraffin-embedded mouse liver tissue using anti-Cytokeratin 19 antibody. Counter stained with hematoxylin.
Fig7: Flow cytometric analysis of MCF-7 cells with Cytokeratin 19 antibody at 1/50 dilution (blue) compared with an unlabelled control (cells without incubation with primary antibody; red). Alexa Fluor 488-conjugated goat anti-rabbit IgG was used as the secondary antibody.
Positive Control | Ags, MCF-7, human liver tissue, mouse liver tissue, human breast carcinoma tissue, human stomach carcinoma tissue. |
---|---|
Application Notes | WB:1:5,000-1:10,000 ICC:1:50-1:200 IHC:1:50-1:200 FC:1:10-1:100 |
Form | Liquid |
---|---|
Storage Instructions | Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles. |
Storage Buffer | 1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide. |
2013 © Omnimabs , All Rights Reserved.